Iconovo AB (publ) (ICO.ST)

8.00 -0.04 (-0.50%) At close: 05:21PM CEST

Iconovo AB (publ)

Medicon Village
Lund 223 81
Sweden
46 4 62 75 67 77
https://www.iconovo.se

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 30

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Johan Waborg	Chief Executive Officer	N/A	N/A	1977
Dr. Orest Lastow	Co-Founder, CTO, Innovation Lead & Director	N/A	N/A	1964
Mr. Henrik Damkjaer Simonssen M.Sc.	Chief Financial Officer	N/A	N/A	1963
Dr. Mikael Arinder	Vice President of Operations	N/A	N/A	1964
Josefin Olsen	HR Manager	N/A	N/A	N/A
Mr. Carl Forslund	Head of Industrial Design	N/A	N/A	N/A
Therese Dahl	Business Controller	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Iconovo AB (publ) develops and licenses inhalation devices in Sweden. It develops ICOres, a flexible multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; ICOone single-dose disposable dry powder inhaler; and ICOone nasal single-dose dry powder inhaler now for nasal use. It serves generic companies. The company has an agreement with Immune System Regulation AB for the development of an inhaled covid-19 vaccine in Iconovo's inhaler ICOone; and Respiratorius to develop dry powder inhalation product, as well as collaboration with Monash h University to. to develop an inhalable and preventive oxytocin treatment to provide effective protection against cotries. Iconovo AB (publ) was founded in 2013 and is based in Lund, Sweden.

Corporate governance

Iconovo AB (publ)’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.